Volition Receives CE Mark for Its NETosis Test

Austin, Texas-based VolitionRx’s Nu.Q NETs test has received a CE mark for detection and evaluation of NETosis, a form of cell death that can cause disease.

The immune system releases neutrophil extracellular traps (NETs) to trap and kill bacteria and viral particles. But excessive production of the NETs can lead to tissue damage and, in severe cases, sepsis, shock and death.

The blood test can detect a biomarker for NETosis, can predict disease severity and can monitor its progression and the response to treatment, the company said.